Abstract
Parkinson's Disease (PD) is a neurodegenerative disorder of high incidence in the global population, which affects men and women mainly between 45 - 54 years-old. Recent studies demonstrate that neuroinflammation is a crucial condition of PD, prompting the search for more effective treatments with a focus on inflammation. In this context, we highlight Annexin A1 (AnxA1), an anti-inflammat…